Skip to content
PubMed This is a summary of 44 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 44 referenced papers

Top Authors

Sarah Elizabeth Flanagan
University of Exeter
Andrew Tym Hattersley
University of Exeter
Kevin Colclough
Royal Devon & Exeter NHS Foundation Trust
Sian Ellard
University of Exeter
Maggie H. Shepherd
University of Exeter
Maria M. Byrne
University College Dublin
Detlef Böckenhauer
Great Ormond Street Hospital
Štěpánka Průhová
Charles University
Petra Dušátková
Charles University

Top Institutions

Ranked by publications Top 10 institutions
05

Charité - Universitätsmedizin Berlin

Berlin, Germany

10 papers
09

Universitat Autònoma de Barcelona

Cerdanyola del Vallès, Spain

11 papers

References

References (44)
  1. 1

    Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations.

    Anglani F, D'Angelo A, Bertizzolo LM, et al.

    SpringerPlus 2015; (4()):492 doi:10.1186/s40064-015-1294-y.

    PMID: 26389017
  2. 2

    Renal tubular acidosis type 4 in pregnancy.

    Jakes AD, Baynes K, Nelson-Piercy C

    BMJ case reports 2016; (2016()).

    PMID: 26989116
  3. 3

    Hepatocyte Nuclear Factor-4 Alfa Mutation Associated with Hyperinsulinaemic Hypoglycaemia and Atypical Renal Fanconi Syndrome: Expanding the Clinical Phenotype.

    Improda N, Shah P, Güemes M, et al.

    Hormone research in paediatrics 2016; (86(5)):337-341 doi:10.1159/000446396.

    PMID: 27245055
  4. 4

    The Common p.R114W HNF4A Mutation Causes a Distinct Clinical Subtype of Monogenic Diabetes.

    Laver TW, Colclough K, Shepherd M, et al.

    Diabetes 2016; (65(10)):3212-7 doi:10.2337/db16-0628.

    PMID: 27486234
  5. 5

    Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood.

    Bacon S, Kyithar MP, Condron EM, et al.

    Acta diabetologica 2016; (53(6)):965-972 doi:10.1007/s00592-016-0890-9.

    PMID: 27552834
  6. 6

    [Takotsubo cardiomyopathy recurrence in patient with chronic kidney disease: case report and literature review].

    Caccetta F, Caroppo M, Musio F, et al.

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 2016; (33(6)).

    PMID: 28134404
  7. 7

    Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer.

    Shepherd M, Brook AJ, Chakera AJ, Hattersley AT

    Diabetic medicine : a journal of the British Diabetic Association 2017; (34(10)):1332-1339 doi:10.1111/dme.13388.

    PMID: 28556992
  8. 8

    MODY in Ukraine: genes, clinical phenotypes and treatment.

    Globa E, Zelinska N, Elblova L, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(10)):1095-1103.

    PMID: 28862987
  9. 9

    Clinical Management of Women with Monogenic Diabetes During Pregnancy.

    Dickens LT, Naylor RN

    Current diabetes reports 2018; (18(3)):12 doi:10.1007/s11892-018-0982-8.

    PMID: 29450745
  10. 10

    HNF4A-related Fanconi syndrome in a Chinese patient: a case report and review of the literature.

    Liu J, Shen Q, Li G, Xu H

    Journal of medical case reports 2018; (12(1)):203 doi:10.1186/s13256-018-1740-x.

    PMID: 30005691
  11. 11

    Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.

    Warncke K, Kummer S, Raile K, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(3)):845-855 doi:10.1210/jc.2018-01696.

    PMID: 30535056
  12. 12

    Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation.

    Arya VB, Kalitsi J, Hickey A, et al.

    Endocrinology, diabetes & metabolism case reports 2019; (2019()).

    PMID: 31096182
  13. 13

    HNF4A Haploinsufficiency in MODY1 Abrogates Liver and Pancreas Differentiation from Patient-Derived Induced Pluripotent Stem Cells.

    Ng NHJ, Jasmen JB, Lim CS, et al.

    iScience 2019; (16()):192-205 doi:10.1016/j.isci.2019.05.032.

    PMID: 31195238
  14. 14

    Renal Tubular Acidosis.

    Bagga A, Sinha A

    Indian journal of pediatrics 2020; (87(9)):733-744 doi:10.1007/s12098-020-03318-8.

    PMID: 32591997
  15. 15

    A Novel HNF4A Mutation Causing Three Phenotypic Forms of Glucose Dysregulation in a Family.

    Chandran S, Rajadurai VS, Hoi WH, et al.

    Frontiers in pediatrics 2020; (8()):320 doi:10.3389/fped.2020.00320.

    PMID: 32670997
  16. 16

    Hnf4a Is Required for the Development of Cdh6-Expressing Progenitors into Proximal Tubules in the Mouse Kidney.

    Marable SS, Chung E, Park JS

    Journal of the American Society of Nephrology : JASN 2020; (31(11)):2543-2558 doi:10.1681/ASN.2020020184.

    PMID: 32764140
  17. 17

    Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother.

    Vlachopapadopoulou EA, Dikaiakou E, Fotiadou A, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(4)):527-530 doi:10.1515/jpem-2020-0302.

    PMID: 33031054
  18. 18

    Two new missense mutations in the protein interaction ASH domain of OCRL1 identified in patients with Lowe syndrome.

    Perdomo-Ramirez A, Antón-Gamero M, Rizzo DS, et al.

    Intractable & rare diseases research 2020; (9(4)):222-228 doi:10.5582/irdr.2020.03092.

    PMID: 33139981
  19. 19

    A young man with recurrent kidney stones and renal failure.

    Gill J, Wiederkehr MR

    Clinical nephrology. Case studies 2020; (8()):85-90 doi:10.5414/CNCS110198.

    PMID: 33163328
  20. 20

    Heterozygous recurrent HNF4A variant p.Arg85Trp causes Fanconi renotubular syndrome 4 with maturity onset diabetes of the young, an autosomal dominant phenocopy of Fanconi Bickel syndrome with colobomas.

    Sheppard SE, Barrett B, Muraresku C, et al.

    American journal of medical genetics. Part A 2021; (185(2)):566-570 doi:10.1002/ajmg.a.61978.

    PMID: 33251707
  21. 21

    Novel Fanconi renotubular syndromes provide insights in proximal tubule pathophysiology.

    Lemaire M

    American journal of physiology. Renal physiology 2021; (320(2)):F145-F160 doi:10.1152/ajprenal.00214.2020.

    PMID: 33283647
  22. 22

    Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia.

    McGlacken-Byrne SM, Mohammad JK, Conlon N, et al.

    European journal of endocrinology 2022; (186(4)):417-427 doi:10.1530/EJE-21-0897.

    PMID: 35089870
  23. 23

    Maturity-Onset Diabetes of the Young: Rapid Evidence Review.

    Kant R, Davis A, Verma V

    American family physician 2022; (105(2)):162-167.

    PMID: 35166506
  24. 24

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  25. 25

    Elucidating the Proximal Tubule HNF4A Gene Regulatory Network in Human Kidney Organoids.

    Yoshimura Y, Muto Y, Omachi K, et al.

    Journal of the American Society of Nephrology : JASN 2023; (34(10)):1672-1686 doi:10.1681/ASN.0000000000000197.

    PMID: 37488681
  26. 26

    Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene.

    Zhang J, Jiang Y, Li J, et al.

    Frontiers in endocrinology 2023; (14()):1237553 doi:10.3389/fendo.2023.1237553.

    PMID: 37711893
  27. 27

    Band-shaped keratopathy in HNF4A-related Fanconi syndrome: a case report and review of the literature.

    Verma A, Mishra DK, Edward DP, Ramappa M

    Ophthalmic genetics 2024; (45(3)):246-251 doi:10.1080/13816810.2023.2285310.

    PMID: 37997707
  28. 28

    Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects.

    Kaci A, Solheim MH, Silgjerd T, et al.

    Human molecular genetics 2024; (33(10)):894-904 doi:10.1093/hmg/ddae027.

    PMID: 38433330
  29. 29

    Management of pregnancy in women with monogenic diabetes due to mutations in GCK, HNF1A and HNF4A genes.

    Crowley MT, Paponette B, Bacon S, Byrne MM

    Frontiers in genetics 2024; (15()):1362977 doi:10.3389/fgene.2024.1362977.

    PMID: 38933924
  30. 30

    Novel Treatment Options in Patients with Maturity-Onset Diabetes of the Young.

    Müssig K

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2025; (133(1)):51-58 doi:10.1055/a-2436-7723.

    PMID: 39379059
  31. 31

    Clinical characteristics, treatment, and treatment switch after molecular-genetic classification in individuals with maturity-onset diabetes of the young: Insights from the multicenter real-world DPV registry.

    Lanzinger S, Laubner K, Warncke K, et al.

    Journal of diabetes 2024; (16(11)):e70028 doi:10.1111/1753-0407.70028.

    PMID: 39511990
  32. 32

    Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene.

    Improda N, Rosanio FM, Annicchiarico Petruzzelli L, et al.

    Frontiers in endocrinology 2025; (16()):1553032 doi:10.3389/fendo.2025.1553032.

    PMID: 40225330
  33. 33

    Neonatal hypoglycaemia in the offsprings of parents with maturity-onset diabetes of the young (MODY).

    Maly J, Urbanova J, Musil V, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2025; (38(6)):570-576 doi:10.1515/jpem-2025-0042.

    PMID: 40287849
  34. 34

    Case Report: Beyond type 1 diabetes: a case of delayed MODY1 diagnosis and successful transition to sulfonylurea therapy.

    Gulisano C, Aloi C, Salina A, et al.

    Frontiers in medicine 2025; (12()):1590935 doi:10.3389/fmed.2025.1590935.

    PMID: 40486195
  35. 35

    Monogenic diabetes: An evidence-based clinical approach.

    Bhattacharya S, Fernandez CJ, Kamrul-Hasan ABM, Pappachan JM

    World journal of diabetes 2025; (16(5)):104787 doi:10.4239/wjd.v16.i5.104787.

    PMID: 40487603
  36. 36

    Descriptive cohort study of transient isolated tubular acidosis in early childhood: experience from a rare kidney disease expert center.

    Charfi H, Bertholet-Thomas A, Bacchetta J, et al.

    European journal of pediatrics 2025; (184(10)):613 doi:10.1007/s00431-025-06394-0.

    PMID: 40935900
  37. 37

    Diazoxide and Continuous Glucose Monitoring as Treatment in a Neonate with Hyperinsulinemic Hypoglycemia due to HNF4A Mutation

    Sotiriou G, Xinias S, Diamantidou V, et al.

    Journal of clinical research in pediatric endocrinology 2025; doi:10.4274/jcrpe.galenos.2025.2025-4-12.

    PMID: 40960027
  38. 38

    A Case of Hyperinsulinemic Hypoglycaemia Associated with Atypical Fanconi Renal Tubulopathy Syndrome Caused by an HNF4A Variant.

    Garriga-Edo S, Peris-Serra L, Ríos Duro H, et al.

    Case reports in nephrology and dialysis 2026; (16(1)):10-19 doi:10.1159/000549545.

    PMID: 41488815
  39. 39

    Tacrolimus-induced type 4 renal tubular acidosis after living donor kidney transplantation with a focus on early diagnosis and targeted treatment: a case report.

    Chang WB, Lee HY

    Clinical transplantation and research 2026; (40(1)):138-141 doi:10.4285/ctr.25.0089.

    PMID: 41527435
  40. 40

    A Case of Oral Semaglutide for Treatment of Hepatocyte Nuclear Factor 4A Maturity-Onset Diabetes of the Young.

    Grennan KN, Singh D, Chindris AM, Wilson JR

    AACE endocrinology and diabetes 2026; (13(2)):177-179 doi:10.1016/j.aed.2025.12.002.

    PMID: 41938282
  41. 41

    Neonatal Hyperinsulinemia and Maternal Diabetes Associated With a Hepatocyte Nuclear Factor 4 Alpha (HNF4A) Variant.

    Takasugi Y, Nakagawa R, Ono H, et al.

    Cureus 2026; (18(4)):e107058 doi:10.7759/cureus.107058.

    PMID: 42147507
  42. 42

    Maturity Onset Diabetes of the Young (MODY): French National Diagnosis and Care Protocol (PNDS, Protocole National de Diagnostic et de Soins).

    Dubois-Laforgue D, Donadille B, Ciangura C, et al.

    Orphanet journal of rare diseases 2026; (17(Suppl 1)).

    PMID: 42227416
  43. 43

    Treatment Options for Patients with Maturity-Onset Diabetes of the Young (MODY): A Systematic Review of Literature: 2026 Update.

    Zagaroli L, Di Berardino A, Petragnano F, et al.

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2026; (17(7)):959-983 doi:10.1007/s13300-026-01884-2.

    PMID: 42295651
  44. 44

    Phenotypic Spectrum of HNF4α-Associated Fanconi Renotubular Syndrome.

    Emma F, Böckenhauer D, Mallett AJ, et al.

    Kidney international reports 2026; (11(8)):106616 doi:10.1016/j.ekir.2026.106616.

    PMID: 42440446